Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
infigratinib
×
Other hematologic neoplasm
×
Clear all
Filters
3
NCT02160041
2019-06-18
CBGJ398XUS04
Novartis
Phase 2
Terminated
84 enrolled
15 charts